DOCSLIB.ORG

P0534 Paper Poster Session III HIV/AIDS Prevalence and Significance of Mycoplasma Genitalium in Women Living with HIV in Denmark

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
P0534 Paper Poster Session III HIV/AIDS Prevalence and Significance of Mycoplasma Genitalium in Women Living with HIV in Denmark P0534 Paper Poster Session III HIV/AIDS Prevalence and significance of Mycoplasma genitalium in women living with HIV in Denmark A.M.R. Madsen1, J.S. Jensen2, K. Thorsteinsson3, M. Storgaard4, T.L. Katzenstein5, F.F. Rønsholt6, I.S. Johansen7, G. Pedersen8, L.N. Nielsen9, A. Lebech3, Å.B. Andersen6 1Department of Clinical Microbiology- Odense University Hospital, Odense, Denmark 2Statens Serum Institut, Copenhagen, Denmark 3Department of Infectious Diseases- Hvidovre, Copenhagen University Hospital, Hvidovre, Denmark 4Department of Infectious Diseases- Skejby, Aarhus University Hospital, Aarhus, Denmark 5Department of Infectiuos Diseases- Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark 6Department of Infectious Diseases- Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark 7Department of Infectious Diseases- Odense University Hospital, Odense, Denmark 8Department of Infectious Diseases- Aalborg University Hospital, Aalborg, Denmark 9Department of Infectious Diseases- Hillerød Hospital, Hillerød, Denmark Objectives Mycoplasma genitalium (M. genitalium) is a sexually transmitted pathogen associated with urethritis in men and cervicitis and pelvic inflammatory disease in women. Several studies have shown a strong association between M. genitalium and HIV infection, especially in African study populations. M. genitalium infection has been shown to cause increased shedding of HIV virus in vaginal fluids and disruption of the genital mucosal barrier, thereby possibly enhancing HIV transmission. It has therefore been suggested that screening and treatment for M. genitalium should become part of HIV prevention strategies. There are few data on women living with HIV (WLWH) and M. genitalium from high-income countries, and none from Scandinavia. Our objective was to determine the prevalence of M. genitalium in WLWH in Denmark. Methods We tested cervical samples collected from 234 WLWH between February 2013 and February 2014. Women were recruited from six Danish HIV centers as part of a larger multicenter study focusing on Human Papillomavirus infection. The median age was 45 years (range 25 to 78 years). Samples were collected in UTM transport medium and M. genitalium was detected by TaqMan™ PCR amplifying a conserved region of the MgPa adhesin gene. Positive results were confirmed by conventional PCR amplifying the 23S rRNA gene, and the resulting PCR products were subsequently sequenced to detect macrolide resistance mediating mutations. Results Of 234 WLWH only 3 (1, 3 %) were infected with M. genitalium, and all carried a strain with a macrolide susceptible genotype. The M. genitalium positive women were 39, 42 and 44 years old respectively. The result is comparable to the prevalence of 1-4 % found in general populations in high-income countries, but much lower than in studies of African and American WLWH, where the prevalence generally has been much higher (10-30 %). The median age was high in our study population compared to other studies of both WLWH and general populations. We are currently awaiting permission to access background data on the study population in order to evaluate our results with data on sexual habits, ethnicity, HIV treatment and immune status. Conclusion The prevalence of M. genitalium infection in WLWH in Denmark is low. Systematic screening for M. genitalium in this group as part of HIV prevention strategies, therefore, does not seem relevant..
Load more

Recommended publications
  • Rigshospitalet's Action Plan for Research
    Research has a special role at Rigshospitalet because, as Denmark’s largest university hospital, we have a specific responsibility not only to treat our current patients as well as possible, but also to procure new knowledge that can ensure that the patients of the future constantly benefit from the gains arising from new knowledge in health sciences. Rigshospitalet is collaborating with the Capital Region of Denmark and the University of Copenhagen on infrastructure and joint cross-disciplinary research efforts. Rigshospitalet plays a central role at regional level because we are responsible for more than half of the research taking place in the Region. Rigshospitalet has an overall vision of being Denmark's international hospital and have set the following goals for the research: - All specializations and disciplines at Rigshospitalet produce and publish research of high international quality. - Rigshospitalet has an international environment and a well-developed research infrastructure. - Rigshospitalet maintains a high international level within clinical research and translational medicine. - Rigshospitalet is one of the driving forces in the international research community. - Rigshospitalet create career opportunities that ensure innovation in research. Rigshospitalet has in 2016 initiated work to enhance research at Rigshospitalet. The initiatives fall within the following three areas: - Management and organisation Integration of research and clinical practice - Activities to make research more visible - Better framework for the individual researcher at Rigshospitalet It is expected that the action plan will contribute to making research more clearly incorporated into management at the departments and to ensuring that cross-disciplinary initiatives, cross-cutting cooperation and hospital priorities for research become significantly more visible internally and externally.
    [Show full text]
  • New Hospital Construction - Future Hospitals in Denmark
    INNOVATING BETTER LIFE SUSTAINABLE HOSPITALS New Hospital Construction - Future Hospitals in Denmark WHITE PAPER SUSTAINABLE HOSPITALS Future Hospitals in Denmark About this white paper Steering Committee This white paper presents the Danish approach to new hospital Danish Ministry of Health, Martin Nyrop Holgersen, [email protected] construction and includes a wide range of innovative solutions that Danish Regions, Kristian Taageby Nielsen, [email protected] contribute to creating sustainable healthcare for the future. It is part North Denmark Region, Niels Uhrenfeldt, [email protected] of a series of white papers that show how Danish solutions can con- Region Zealand, Helle Gaub, [email protected] tribute to increase efficiency in healthcare while empowering patients Region of Southern Denmark, Torben Kyed Larsen, [email protected] and staff. Danish Export Association, Thomas Andersen, [email protected] Danish healthcare innovation is not exclusive for the Danes: many Systematic, Jacob Gade, [email protected] years of global presence show that our healthcare products and solu- tions create value internationally. Danish ideas and products are used Contributors every day in hospitals, medical clinics, ambulances, and nursing homes 3XN, Stig Vesterager Gothelf, [email protected] across the world. Agitek, Jean-Paul Bergmann, [email protected] Arkitema Architects, Birgitte Gade Ernst, [email protected] We hope to inspire you and would like to invite you to Denmark to Bim Equity, Ida Maria Sandgreen, [email protected] learn more about the Danish
    [Show full text]
  • The Capital Region of Denmark's Strategy for Health Research 2018
    The Capital Region of Denmark THE CAPITAL REGION OF DENMARK´S STRATEGY FOR HEALTH RESEARCH 2018-2022 FOREWORD In the Capital Region of Denmark we have a robust health service that works every day to ensure that patients and citizens in the region can enjoy first-rate quality and access to new, advanced treatments. In these changing times, however, our health service is constantly being confronted with new challenges and opportunities. Our society depends on health research to open the door to the latest knowledge and findings and the best methods and technologies that guarantee patients excellent healthcare and quality of life. Research must be treated as a core activity in the health service and must therefore be promoted. The aim of our new Strategy for Health Research 2018-2022 is to focus our research efforts on four priority research fields, each of which plays a vital role in the develop- ment of the health service as a whole. The purpose of the research strategy is to bolster research in the region by enhancing research environments and increasing funding. Research in health prevention and health system organisation can play a part in resolving specific societal challenges. At the same time research fosters innovation and leads to a high level of training and education, ensuring that healthcare staff can continuously improve their skills in core areas. Research lays the foundation for strong and meaningful cooperation with external partners across sectors: the health service, universities, knowledge institutions, municipalities, practitioners and business and industry. Health research in the Capital Region is already thriving and has numerous research environments of a high international calibre.
    [Show full text]
  • Spot På Publikationer 2019
    Region Hovedstaden Center for Regional Udvikling Spot publikationer på DATA OM VIDENSKABELIGE PUBLIKATIONER 2019 Indhold 4 Indledning 6 Udvikling på børne- og ungeområdet 2010-2019 10 Udvikling på psykiatri området 2010-2019 14 Publikationer i Region Hovedstaden 16 Tidsskrifter med højeste Journal impact factor for året 2019 18 Spot på Amager og Hvidovre Hospital 20 Spot på Bispebjerg og Frederiksberg Hospital 22 Spot på Herlev og Gentofte Hospital 24 Spot på Nordsjællands Hospital 26 Spot på Region Hovedstadens Psykiatri 28 Spot på Rigshospitalet – centrene samlet 30 Spot på Center for Hjerte-, Kar-, Lunge- og Infektionssygdomme, Rigshospitalet 32 Spot på Center for Kræft- og Organsygdomme, Rigshospitalet 34 Spot på Diagnostisk Center, Rigshospitalet 36 Spot på HovedOrtoCentret, Rigshospitalet 38 Spot på Juliane Marie Centret, Rigshospitalet 40 Spot på Neurocentret, Rigshospitalet 42 Spot på Tværgående enheder, Rigshospitalet 44 Spot på Region Hovedstadens Akutberedskab 44 Spot på Region Hovedstadens Apotek 45 Spot på Steno Diabetes Center Copenhagen 45 Spot på Bornholms Hospital 46 Om Spot på publikationer 2019 Redaktion: Region Hovedstaden, Center for Regional Udvikling Kongens Vænge 2, 3400 Hillerød Grafisk opsætning: RegionH Design Kontakt: [email protected] November 2020 Indledning Det handler om liv Det handler om liv i Region Hovedstaden, borgernes og patienternes liv. Forskning på hospitalerne handler om liv i ordets bredeste forstand, som på bedste vis kan medvirke til at løse sundhedsvæsenets udfordringer. Derfor er forskning også en kerneydelse i Region Hovedstaden, og denne rapport vil vise data for forskningspublikationerne i Region Hovedstaden i 2019 og bidrage til at belyse tendenser og udviklinger i denne kerneydelse. Rapporten viser forskningspublikationer for alle hospitalerne, centre og forskningsenheder.
    [Show full text]
  • COVID-19 Initiatives in 2020 1
    Novo Nordisk Foundation - COVID-19 initiatives in 2020 1 COVID-19 initiatives in 2020 The Novo Nordisk Foundation’s response to the coronavirus pandemic Grants have been awarded in the areas of scientific research, education and outreach, patient care, diagnostics as well as for social and humanitarian efforts. Establishment of TestCenter Research into the long-term health Danmark: consequences of COVID-19 illness: DKK 250m DKK 40,0m (for distribution in 2021) Emergency production of ethanol: Humanitarian grants: DKK 8,75m DKK 37,4m Emergency grants for COVID-19 Educational support for vulnerable projects in the Danish Realm: children after the lockdown: DKK 84,5m DKK 4,7m Grants for other COVID-19 research: Total amount: DKK 34,8m DKK 460,15m Read more about the Novo Nordisk Foundation’s efforts at: novonordiskfonden.dk/en/about-the-foundation/initiatives-covid-19/ Novo Nordisk Foundation - COVID-19 initiatives in 2020 3 An extraordinary situation calls for collaboration With the coronavirus pandemic, Denmark was plunged into a of our Board of Directors and employees. I am happy to see that health crisis as well as an economic crisis that required – and many of the projects we have supported have benefited people continues to require – an extraordinary effort from the whole of and society. You can read more about them at the Foundation’s society. The crisis is not over yet, but with vaccines on the way, homepage and at sciencenews.dk. there is light at the end of the tunnel, and hopefully we can begin to see a return to normal life in the course of 2021.
    [Show full text]
  • [email protected]' Subject: VS: Høring Vedr
    From: Heidi Pabst Andersen Sent: Wed, 9 Sep 2020 13:36:27 +0200 To: '[email protected]' Subject: VS: Høring vedr. udviklingsbidrag 2021 Attachments: forslag til budget 2021v20 (003).pdf Administrationen i Dragør Kommune tiltræder hermed regionens forslag til fastsættelse af udviklingsbidraget for 2021, da udviklingsbidraget svarer til det i økonomiaftalen mellem regeringen og Danske Regioner fastsatte bidrag for 2021 og som er en pris- og lønfremskrivning af bidraget for 2020. Administrationens tiltrædelse er med forbehold for kommunalbestyrelsens endelige godkendelse. I Dragør Kommune finder vi det fornuftigt, at vi skal betale det beløb, som svarer til aftalen der er indgået mellem Danske Regioner og regeringen. Vi ser ligeledes med tilfredshed på, at Region Hovedstaden ikke gennemfører generelle besparelser. Men ser alligevel med en vis bekymring på, at bloktilskuddet til Region Hovedstaden i 2021 reduceres med 44 mio. kr. Vi tilslutter os intentionerne bag ved styringsmodellen nærhedsfinansiering, og vil, ud fra fastlagte og klare aftaler, gerne understøtte, at intentionerne kan realiseres. Vi vil således meget gerne lokalt arbejde for færre genindlæggelser, og ser frem til de fremtidige drøftelser omkring en betalingsmodel, hvor vi kompenseres for de nye opgaver, som vi påtager os. I Dragør Kommune sætter vi pris på det gode samarbejde, og synes, at der overordnet set lægges op til en ramme, hvor det gode samarbejde kan fortsætte i 2021. Venlig hilsen Heidi Pabst Andersen Borgmestersekretær Borgmestersekretariat og Personale
    [Show full text]
  • DEPARTMENT of CLINICAL MICROBIOLOGY , RIGSHOSPITALET, UNIVERSITY of COPENHAGEN Juliane Maries Vej 22, 2100 Copenhagen, Denmark
    DEPARTMENT OF CLINICAL MICROBIOLOGY , RIGSHOSPITALET, UNIVERSITY OF COPENHAGEN Juliane Maries Vej 22, 2100 Copenhagen, Denmark Contact person: Main services (diagnostic) Outline of what a visitor can expect from a one day, Clinical bacteriology, virology, parasitology, mycology, serology and one week and one month visit to the department: Mr. Prof, Dr. Med. Scient. Niels Høiby, MD hospital hygiene. All modern and conventional methods are used For one day Phone +4535457778, Fax +4535456412 except culture of mycobacteria (centralized at the State Seruminstitute). The MD’s of the department of clinical microbiology One day visit: discussions with academic personal, visit to the different Email: [email protected] have 22 clinical conferences at the Rigshospital each week at ID, ICU, laboratories and information about the methods used and the clinical Website: www.rigshospitalet.dk Haematology-Oncology, Orthopedic Surgery, Neurosurgery, microbiology work in the department including advise and recommendations Cardiology, Pediatrics including Cystic Fibrosis and also the to clinicians by phone or at face-to-face conference at the clinical Paraplegia/Tetraplegia clinic. departments. Receive selected articles about e.g. antibiotic policy, infection control, research etc. which reflect the daily work. The department of clinical microbiology has a 24-hr on call Epidemiological characteristics of the area: microbiology service for Rigshospitalet (a junior doctor in front and a For one week Low level of MRSA, relatively low level of resistant Gram-negative rods specialist in clinical microbiology as back up) and on night call for most Discussions with academic personal, visit to the different laboratories and compared to most other European countries. of the Capital Region of Zealand (1.5 mio inhabitants).
    [Show full text]
  • Hospitalsplan 2020
    Region Hovedstaden HOSPITALSPLAN 2020 Juni 2015 HOSPITALSPLAN 2020 Design RegionH Design Region Hovedstaden Center for Sundhed Kongens Vænge 2 3400 Hillerød Telefon: 3866 5000 E-mail: [email protected] www.regionh.dk/hospitalsplan 2 HOSPITALSPLAN 2020 FORORD Region Hovedstaden er landets største sundhedsvæsen – og vi har som mål, at det også skal være landets førende sundhedsvæsen. Regionens ’Hospitalsplan 2020’ bygger på grundprincippet om, at behandlingen skal foregå på et højt fagligt niveau, den skal organiseres under hensyntagen til de økonomiske rammer og så tæt på patien- tens bopæl som fagligt muligt under hensyn til sammenhængen i patientforløb. Hospitalsplanen udstikker dermed en langsigtet ramme for udviklingen af vores hospitalsvæsen. Et vigtigt afsæt for hospitalsplanen er, at den skal afspejle borgernes forventning til et topmoderne sundhedsvæsen, som er kendetegnet ved behandling af høj kvalitet på internationalt niveau – uanset om man har en fysisk eller psykisk sygdom. Samtidig står vi også overfor nogle store økonomiske udfor- dringer de kommende år, og vores hospitalsplan skal derfor også sikre en struktur, som understøtter et effektivt hospitalsvæsen. For at hospitalsplanen lever op til de krav, der stilles af vores patienter, deres pårørende og vores fagfolk, beslutter regionsrådet hvert år, om det er nødvendigt at ændre i planen. Den politiske forank- ring af ændringer i hospitalsplanen er med til at sikre løbende fokus på forbedringer - samtidig med at patienter og medarbejdere oplever en stabil retning for udviklingen af sundhedsvæsnet. I år har regionsrådet besluttet at ændre mere i hospitalsplanen end tidligere. Det er sket, både fordi forudsætningerne på en række områder har ændret sig, men også fordi vi med Budgetaftalen for 2015 traf en beslutning om at ændre regionens overordnede hospitalsstruktur.
    [Show full text]
  • Forskningsevaluering 2018 - Tal Og Data Om Forskning I Region Hovedstaden I 2017
    Forskningsevaluering 2018 - Tal og data om forskning i Region Hovedstaden i 2017 Indholdsfortegnelse INDLEDNING .............................................................................................................................................................................................................................................. 5 OVERBLIK FOR REGION HOVEDSTADEN ................................................................................................................................................................................................. 7 Samarbejde i Region Hovedstaden ......................................................................................................................................................................................... 7 Forbrugte ressourcer til Forskning & Udvikling samt antal publikationer................................................................................................................. 8 Forbrugte ressourcer til Forskning og Udvikling i Region Hovedstaden 2010 - 2017 .......................................................................................... 9 Nøgletal for forbrugte ressourcer i Regionen .................................................................................................................................................................... 10 Eksternt forbrugte ressourcer ................................................................................................................................................................................................
    [Show full text]
  • Aftale Om Region Hovedstadens Budget for 2021
    Region Hovedstaden Budgetaftale 2021 Indhold Nye og kendte udfordringer og løsninger ........................................................ 3 En effektiv og fokuseret administration ......................................................... 4 Det handler om liv ................................................................................. 4 Børnenes region .................................................................................. 6 Det nære og sammenhængende sundhedsvæsen ............................................ 8 Patientrettigheder .............................................................................. 10 Digitalisering ..................................................................................... 12 Fremtidens hospital ............................................................................. 14 Den fortsatte coronaudfordring ................................................................ 20 Kost, klima og køkkener ........................................................................ 22 Region Hovedstadens Psykiatri ................................................................ 23 Lighed i sundhed ................................................................................ 25 Høj kvalitet i regionens specialiserede sociale tilbud ........................................ 26 Regional udvikling .............................................................................. 27 Sundhedsforskning ............................................................................. 28 Bilag 1 – Sundhed ..............................................................................
    [Show full text]
  • Download Pamphlet About the Capital Region of Denmark
    Capital Region of Denmark CAPITIAL REGION OF DENMARK Growth and quality of life A PART OF THIS IS THE CAPITAL REGION OF DENMARK • 2.568 km2 • 29 municipalities • 1,807,404 inhabitants • 40% of the Danish gross domestic product produced here Gribskov Helsingør Halsnæs Fredensborg Nord Hillerød Hørsholm Allerød Rudersdal Frederikssund Midt Furesø Lyngby-Taarbæk Egedal Gentofte Gladsaxe Ballerup Herlev Byen København Rødovre Albertslund Frederiksberg Glostrup Høje-Taastrup Brøndby Hvidovre Vallensbæk Ishøj Syd Tårnby Dragør Bornholm Allinge Rønne Neksø 41 politicians meet monthly in the Regional Council to establish the framework for development in the region. GROWTH AND QUALITY OF LIFE – OUR GUIDING PRINCIPLES Denmark comprises five regions that are responsible for solving health, environmental, business and social issues. As the largest region, the Capital Region of Denmark has high ambitions, whether it’s a question of growth and employment in innovative companies or quality of life in the form of a green environment and a world-class health system. In the Regional Council we have four agreed-upon objectives. THE PATIENT’S CIRCUMSTANCES DETERMINE THEIR CARE If one day you need to be hospitalised, then your situation will determine your care. People have various backgrounds and resources, which is why they should be included and taken into consideration to provide care that achieves the best possible outcome. HIGH LEVEL OF PROFESSIONAL QUALITY Your treatment and care must occur under the highest professional standards. That’s why we work systematically to offer the best possible care and to minimise the risk of errors and injuries as much as possible. EXTENSIVE KNOWLEDGE ENVIRONMENTS The Capital Region of Denmark has excellent research environments, including within the health system, where research is translated into better treatments and new patents.
    [Show full text]
  • Cancer Treatment and Prevention
    THE DANISH MODEL FOR CANCER TREATMENT AND PREVENTION PATIENTS AS PARTNERS RESEARCH AND TREATMENT Patient organizations Scientific Society Concrete Initiatives NATIONAL CANCER PLANS Regional government National government WELCOME Imagine an innovation district in the heart of Copenhagen with 30,000 businesses, employees, researchers and students specialising in life sciences and green technologies, huge investments in state-of-the-art research facilities and transport infrastructure, green parks and attractive housing. Imagine a place where collaboration and sharing knowledge is the common goal. This is Copenhagen Science City. You are invited to join. Copenhagen Science City has a world-class eco-system for cancer research and the development of new treatments. Rigshospitalet (the University Hospital of Copenhagen) is located in the centre of Copenhagen Science City right next to the University of Copenhagen’s Faculty of Health and Medical Sciences and Copenhagen Bio Science Park, which hosts more than 70 biotech companies. Copenhagen Science City is therefore a central part of the Danish Model. The ESMO 2016 Congress is a unique opportunity to share knowledge and enter into partnerships that can foster new solutions and enhance the quality of life for Europeans and patients worldwide. We look forward to meeting you there. ”In Copenhagen Science City, we have created an innovative environment in which the health sector, researchers, and businesses work closely together to develop and convert research into new, innovative products. Working side by side in close strategic partnerships creates unique opportunities that benefit not only the companies and the health sector but also the patients.” Frank Jensen, Lord Mayor of Copenhagen ”I am thrilled that we’re able to gather more than 20,000 researchers and companies in the Capital Region of Denmark.
    [Show full text]